The deadly risk of late referral.

2003; 8: 190 25. Johansson B-L, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabetic Med 2000; 17: 181–189 26. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P, Wahren J. Amelioration of sensory nerve dysfunction by Cpeptide in patients with type 1 diabetes. Diabetes 2003; 52: 536–541 27. Davies HTO, Crombie IK, Lonsdale M, Macrae WA. Consensus and contention in the treatment of chronic nervedamage pain. Pain 1991; 47: 191–196 28. Kunz NR, Goli V, Lei D, Rudolph R. Treating painful diabetic neuropathy with venlafaxine extended release. Diabetes 2000; 49 [Suppl 1]: A165 29. Detke M, Goldstein D, Lu Y, Iyengar S, Lee T. Efficacy of duloxetine in the treatment of the pain associated with diabetic neuropathy. Diabetologia 2003; 46 [Suppl 2]: A315 30. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003; 22: 1284–1289 31. Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. J Am Med Assoc 1998; 280: 1831–1836 32. Sharma U, Young J, Lamoreaux L, Garofalo E. Pregabalin effectively relieves pain in patients with painful diabetic neuropathy. Diabetes 2002; 51 [Suppl 2]: A79 33. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105: 71–78 34. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003; 60: 927–934 35. Leonard DR, Farooqi MH, Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebocontrolled study with monochromatic near-infrared treatment. Diabetes Care 2004; 27: 168–172 36. Weintraub MI, Wolfe GI, Barohn RA et al. for the Magnetic Research Group. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil 2003; 84: 736–746